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Abstract  
 
Aims:  Recent research suggests the possibility of a bi-directional relationship 
whereby hypoglycaemia is a risk factor for dementia, and also where 
dementia increases risk of hypoglycaemia. We aimed to examine this 
relationship in older patients with diabetes mellitus treated with glucose 
lowering agents. 
Materials and Methods: We searched MEDLINE and EMBASE over a ten year 
span 2005 to 2015 (with automated PubMed updates to August 2015) for 
observational studies of the association between hypoglycaemia and cognitive 
impairment or dementia in participants aged >55 years. Assessment of study 
validity was based on ascertainment of hypoglycaemia, dementia and risk of 
confounding. We conducted random effects inverse variance meta-analyses, 
and assessed heterogeneity using the I2 statistic. 
Results: We screened 1177 citations, and selected twelve studies, with nine 
suitable for meta-analysis. There were a total of 1,439,818 participants, mean 
age 75 years.  Meta-analysis of five studies demonstrated a significantly 
increased risk of dementia in patients who had hypoglycaemic episodes, pooled 
odds ratio of 1.68 (95% Confidence Interval 1.45, 1.95).  We also found a 
significantly increased risk of hypoglycaemia in patients with dementia, pooled 
odds ratio from five studies 1.61 (95% Confidence Interval 1.25, 2.06). 
Limitations are heterogeneity in the meta-analysis, and uncertain 
ascertainment of dementia and hypoglycaemic outcomes and temporal 
relationships. Publication bias may favour reporting of more significant findings. 
Conclusions: Our meta-analysis demonstrates a bi-directional relationship 
between cognitive impairment and hypoglycaemia in older patients. Glucose 
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lowering therapy should be carefully tailored and monitored in older patients 
who are susceptible to cognitive decline. 
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Introduction 
Diabetes and dementia are two major chronic diseases, affecting millions of 
people worldwide.  In the UK, 5% of people aged over 80 with Type 2 diabetes 
mellitus also have co-existing cognitive impairment/dementia[1].  Managing this 
group of people can be challenging, as clinicians try to balance the need for 
good blood sugar control against the avoidance of side-effects of drug therapy, 
such as hypoglycaemia.[2, 3] 
 
Previous research has indicated that patients with diabetes mellitus have an 
increased risk of cognitive decline over time[4]. Concerns have also recently 
been raised regarding the possibility of a bi-directional relationship between 
hypoglycaemia in older patients with Type 2 diabetes mellitus and cognitive 
impairment/dementia[5]. This bi-directional relationship potentially creates the 
possibility of a vicious circle whereby cognitive impairment occurs as a result of 
recurrent hypoglycaemic events, and the subsequent deterioration in cognitive 
function causes patients to be at even greater risk for further hypoglycaemia. 
Hence, strategies should be developed for the individualized management of 
patients with these co-morbid conditions, aimed at minimizing the risk and 
serious consequences of hypoglycaemia. 
 
In a previous systematic review dating back to 2005, Cuikerman et al argued 
that there is little evidence to say that hypoglycaemia leads to chronic cognitive 
impairment.  In contrast, a more recent review article by Bordier et al concludes, 
based on emergent new evidence, that hypoglycaemia can affect long-term 
cognitive function in older patients [4, 6].  Bordier et al. also point to the growing 
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accumulation of research evidence suggesting that patients with cognitive 
impairment are at increased risk of hypoglycaemia. Conversely, a systematic 
review by Bloomfield et al in 2012 reported that whilst severe hypoglycaemia 
might contribute to increased long-term mortality, lower quality of life and higher 
anxiety, there was no robust evidence to support the association between 
hypoglycaemia and other important adverse events in older people such as 
dementia, falls, and cardiovascular events.[7] 
 
In light of the contrasting views, we aimed to systematically review and analyze 
the recent evidence on the relationship between hypoglycaemia and cognitive 
impairment/dementia in older patients treated with glucose lowering drugs. 
 
Material and Methods 
 
Data sources and searches 
Full details of the search strings are listed in the Supplementary Appendix. We 
searched MEDLINE and EMBASE for the last 10 years up to March 2015 with 
English language restriction, and we also checked the bibliographies of 
included studies for any potentially suitable studies. In addition, we signed up 
for the PubMed automated update email notifications of any newly published 
articles on hypoglycaemia in older patients (most recent update August 2015). 
We chose only the last 10 years, as we wanted the most up to date studies 
based on contemporary practice and populations. Moreover, studies before 
2005 have been reviewed in Cuikerman et al’s systematic review. 
 
Study selection 
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We selected prospective and retrospective cohort studies reporting on the 
association between hypoglycaemia and cognitive impairment or dementia in 
older participants aged >55 years who were treated with glucose lowering 
agents.  We excluded studies that reported on the association between 
diabetes and cognitive decline, but which did not explicitly assess 
hypoglycaemic events.  Reviews and abstracts were also excluded. 
 
Data extraction and quality assessment 
YKL and KM performed study screening and data extraction.  Both 
independently scanned all titles and abstracts for potentially relevant articles, 
before proceeding to obtain full text versions for further checking. Any 
uncertainties and discrepancies were resolved through discussion.  We used a 
standardized form for data collection, which included details of the study design, 
setting, date of the study, country of origin, selection criteria, participant 
characteristics and outcome measures.  We extracted odds or hazard ratios as 
a measure of the association between hypoglycaemia and dementia (and vice 
versa). 
For the assessment of study validity, both reviewers independently checked the 
methods used for recording hypoglycaemic episodes and determining cognitive 
decline, as well as adjustment for confounding factors. 
 
Data synthesis and analysis 
We conducted a random effects meta-analysis of odds ratios using inverse 
variance method (Revman 5.3, Nordic Cochrane Centre, Kobenhavn).   We 
assessed heterogeneity using the I2 statistic and visual inspection of the forest 
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plots. As both dementia and hypoglycaemic episodes are uncommon events, 
we considered odds ratios and hazard ratios suitable for pooling together in the 
meta-analysis. 
We aimed to construct a Funnel plot if we had more than 10 studies in the meta-
analysis, with no evidence of statistical heterogeneity. 
We did not submit a protocol to a registry of systematic reviews. 
 
Results 
After screening 1177 citations, we included 12 studies.   The flow chart of the 
study selection is also shown in Supplementary Appendix Figure).  
Characteristics and results of the included studies are shown in Supplementary 
Appendix Table, while assessment of study validity is reported in Table 1. 
 
The included studies had a total of 1,439,818 participants (sample size from 60 
to 893,115) with mean age 75.  53% of the participants were male (from the 
studies that reported gender distribution).  Geographical locations were diverse 
and included North America, Canada, Europe and Asia. All the studies 
evaluated patients with Type 2 Diabetes Mellitus, who were receiving insulin 
and/or oral agents. 
 
 
Measurement of hypoglycaemic events 
Five studies used hospital records[8-12], four studies relied on self-reported 
hypoglycaemic episodes [13-16], one relied on symptoms without apparent 
cause or blood glucose levels <2.8mmol/L (collected as part of adverse events 
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reports in a trial)[17] , one relied on insurance database records[18],  and one 
did not state the method of ascertaining hypoglycaemic events[18, 19].   
We considered self-reporting to be potentially unreliable, because a patient may 
experience non-specific symptoms suggestive of hypoglycaemia, without the 
blood sugars being documented at a level when treatment is necessary 
(<4mmol/L). 
 
Measurement of cognitive impairment 
We found that a diverse variety of tests were used for ascertaining cognitive 
impairment, which reflects the reality of there not being one single diagnostic 
test for dementia.  Some studies relied on diagnostic coding in medical or 
insurance records, where it was unclear if any specific validation based on 
cognitive testing had taken place. 
 
Confounding factors 
All studies used multivariable regression models to adjust for confounding. 
Five studies excluded patients with either established dementia or cognitive 
impairment [11, 12, 14, 16, 20]. 
 
 
Meta-analysis 
Nine studies were included in meta-analysis.  One study had data for both 
hypoglycaemia being a predictor for dementia and vice versa (dementia being 
a predictor for hypoglycaemia)[11].  
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Hypoglycaemia as a predictor for dementia  
We identified five relevant studies that evaluated the relationship of 
hypoglycaemia as a predictor of dementia [11, 12, 18-20]. (Figure 1a)  The 
meta-analysis shows an increased risk of dementia in patients known to suffer 
from hypoglycaemic episodes, with a pooled odds ratio of 1.68 (95% 
Confidence Interval 1.45, 1.95).  We detected some degree of heterogeneity 
with I2 = 64%. 
 
Dementia as a predictor for hypoglycaemia  
We identified five relevant studies that evaluated the relationship of dementia 
as a predictor of increased risk of hypoglycaemia[14] [8, 11, 17, 21]. (Figure 1b) 
The meta-analysis shows an increased risk of hypoglycaemia in patients known 
to have dementia, with a pooled odds ratio of 1.61 (95% Confidence Interval 
1.25, 2.06).  We identified substantial heterogeneity in this meta-analysis 
(I2=84%). 
 
Sensitivity analysis focused on results of studies at lower risk of bias is reported 
in Supplementary Results. 
 
Narrative synthesis of studies not included in meta-analysis 
There were three studies that did not provide odds ratios for the relationship 
between diabetes and dementia. [13, 15, 16] The three studies were 
methodologically similar in that they carried out a diverse battery of cognitive 
tests in patients who had self-reported hypoglycaemia.  
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Aung et al. conducted cognitive testing in 1066 participants in the Edinburgh 
Type 2 Diabetes Study, and found that self-reported history of severe 
hypoglycaemia was associated with reduced late-life general cognitive 
ability.[13] Feinkohl et al subsequently reported on a subset of participants 
(n=831) from Aung’s study who had four years follow-up with repeat cognitive 
testing. [22]  Only four participants were classified as having dementia after four 
years, thus making it impossible to evaluate the association between dementia 
and incident hypoglycaemia.  Nevertheless, poorer cognitive function at 
baseline was noted in those who developed incident hypoglycaemia. Incident 
hypoglycaemia was also associated with subsequently greater decline in global 
cognitive ability measured at the four year follow-up. 
Gao et al. demonstrated in a Chinese study that self-reported history of 
hypoglycaemic events was associated with mild cognitive impairment.[15] In 
contrast, Munshi reported that patients who were found to have cognitive 
impairment reported a higher (not statistically significant) incidence of 
hypoglycaemic events.[16] Although Gao and Munshi both took steps to 
exclude patients with known dementia, the major limitation is the uncertain 
temporal relationship, where it is unclear if the cognitive impairment or the 
hypoglycaemia events came first. 
 
Publication bias and selective outcome reporting 
Although we did not construct a funnel plot because we did not have more than 
ten studies in the meta-analyses, we were able to identify the possibility of 
reporting bias. For instance, Bruce et al. stated in their study that 
hypoglycaemia did not increase the likelihood of cognitive impairment[14]. 
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However, these data were not available for our meta-analysis (odds ratios were 
not given) because the authors selective chose to omit non-statistically 
significant findings whilst reporting significant ones. Similarly, Munshi et al. did 
not report the non-statistically significant adjusted odds ratio for the risk of 
hypoglycaemia in those with cognitive impairment[16].  The incomplete 
reporting of null results means that our meta-analyses may potentially over-
estimate the strength of the association between hypoglycaemia and cognitive 
impairment.  
 
Discussion 
Our meta-analyses present quantitative evidence of a bi-directional relationship 
between cognitive impairment and hypoglycaemia in older patients. There is 
reasonable data from five studies identifying the increased likelihood of 
cognitive decline or dementia in those with a history of hypoglycaemic events. 
Similarly, evidence from the meta-analysis of five studies also reveals an 
identifiable relationship the other way around, where patients with cognitive 
impairment have greater risk of developing hypoglycaemic events. These 
findings remained apparent even in a sensitivity analysis focused on three 
studies of higher quality. 
 
Our meta-analysis is clinically important because patients with co-morbid 
diabetes and cognitive impairment may find themselves in an awkward spiral 
descent resulting in ever-worsening cognitive decline and more frequent 
hypoglycaemic episodes at the same time. In such patients, there is an 
argument that the possibility of a vicious circle could be broken by abandoning 
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the almost relentless pursuit of normoglycaemia, and instead focusing on a 
more balanced strategy towards reducing the risk of hypoglycaemic events. 
 
Hypoglycaemic adverse events are a particular problem in older patients 
because of impaired hypoglycaemia awareness.  This was highlighted by 
Bremer et al, who found an age-related (over 65) impairment of hypoglycaemia 
that did not depend on altered neuroendocrine counter-regulation[23].  Older 
people with dementia and diabetes may have difficulty with self-management 
due to their cognitive decline, greater susceptibility to hypoglycaemia and 
having poorer access to diabetes services and monitoring[24].  Recent 
evidence from Taiwan and Korea shows a worrying sharp rise in emergency 
admissions for hypoglycaemia in older patients, which lends further weight to 
the importance of our meta-analysis.[25, 26] In addition, studies that used 
rigorous methods for ascertaining hypoglycaemia have found that the burden 
of hypoglycaemic events may be higher than envisaged [27] [28] 
 
A number of mechanistic reasons have been identified to explain why 
hypoglycaemic events can lead to cognitive impairment (e.g. 
neuroglycopaenia).  Bordier et al report that in animal models acute 
hypoglycaemia exacerbates neuronal damage, however, the impact of 
repeated hypoglycaemic episodes was less clear.[6] Experimental studies in 
rats found that severe hypoglycaemia caused damage to neurons in the cortex 
and hippocampal regions, and that diabetes was associated with greater 
susceptibility to such damage. [29] 
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Adults with diabetes have been found to have structural changes to their brain, 
including atrophy and leukariosis, but it is not clear what the relative impact of 
hypo/hyperglycaemia is on these changes[30].  Imaging and spectroscopy 
studies in diabetes have demonstrated significant reductions in the gray matter 
content of N-acetylaspartate and glutamate, which is associated with neuronal 
loss or dysfunction [30]. Magnetic resonance imagining in patients with Type 1 
diabetes with hypoglycaemia unawareness showed a significantly reduced 
thalamic response during a hypoglycaemic episode compared to control 
participants. It remains unclear though how recurrent hypoglycaemia might 
alter thalamic response.  
 
A recent paper suggests that Type 2 diabetes appears to also be associated 
with tau-phosphorylation leading to neurodegeneration, but the mechanism is 
unclear. Other research suggests that reduced glucose uptake into the brain 
worsens neurodegenerative process associated with Alzheimer's disease [31, 
32].  However, on the other hand, Mayeda et al highlighted that the individual 
complex disease processes of Type 2 diabetes and the development of 
dementia make it difficult to identify the mechanism linking the two[33].  
 
We recognize important limitations in our meta-analyses, principally stemming 
from observational datasets that reveal associations but cannot prove causality. 
Moreover, there is some heterogeneity, the temporal relationships are not 
always clear and our search was limited to English-language articles. Detection 
of hypoglycaemia is a major issue that may have biased the estimates in either 
direction. For instance, poor recording or failure to accurately capture 
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hypoglycaemia can bias the results towards the null. Conversely, patients with 
dementia may have been more closely monitored with frequent healthcare 
visits, thus resulting in bias towards detecting higher frequency of 
hypoglycaemic events as compared to those without dementia. Finally, we are 
conscious of publication and selective outcome reporting biases where null or 
negative findings are not fully reported, thus resulting in inflated estimates of 
association in the meta-analyses. 
 
Nevertheless, we believe that our results have important implications, 
particularly in light of the substantial proportion of patients at risk of 
hypoglycaemia[34]. Clinicians should look at the whole patient and their 
associated comorbidities rather than over-emphasize a single target (for which 
there is little robust evidence of benefit in the elderly). Equally, variability in 
blood glucose (swings of too high and too low) have not been explored in this 
group, and further research using continuous glucose monitoring would be 
valuable in determining the true pattern over periods of weeks. 
Clinicians are faced with the challenge of trying to balance the need for tight 
blood sugar control in accordance with national targets, against pragmatism 
and the avoidance of adverse drug reactions, in particular hypoglycaemia.  
There is an urgent need to further evaluate the burden of hypoglycaemia and 
to optimize the benefit: harm profile of glucose-lowering drugs in older people 
with co-morbid diabetes and dementia.  Further mechanistic research is also 
needed to better understand how diabetes interacts with the ageing process[30] 
particularly with regards to recurrent hypoglycaemia and long-term cognitive 
decline. 
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Supplementary Figure. PRISMA flow diagram (see Supplementary 
Appendix) 
 
Figure 1 Meta-Analysis of Relationship between hypoglycaemia and 
dementia 
a) Pooled Odds Ratio of hypoglycaemia as a predictor for dementia 
b) Pooled Odds Ratio for Dementia as predictor for hypoglycaemia 
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Figure 2 
 
Meta-Analysis of Relationship between hypoglycaemia and dementia 
 
c) Pooled Odds Ratio of hypoglycaemia as a predictor for dementia 
 
 
 
 
d) Pooled Odds Ratio for dementia as predictor for hypoglycaemia 
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Table 1: Study outcomes, results and risk of bias 
 
Study ID Method of diagnosing 
cognitive impairment 
Method of diagnosing 
or determining that 
patients had 
hypoglycaemia 
Statistical adjustments for 
confounding factors  
Results (relationship 
between hypoglycaemia 
and cognitive impairment 
and vice versa) 
Aung 2011 
[13] [22] 
Faces and Family 
Pictures subtest, Logical 
Memory from Wechsler 
Memory Scale III, Verbal 
Fluency test, Trail-
Marking Test, Mill Hill 
Vocabulary Scale Score 
Self-reported requiring 
extra help (severe hypo) 
– no verification by 
plasma glucose 
Reports of milder hypos 
not collected 
Multivariable models adjusted 
for age/sex/estimated prior 
cognitive ability, anxiety, 
depression, duration of 
diabetes, insulin use, alcohol, 
vascular disease 
Severe hypos associated 
with reduced general 
cognitive ability. For those 
with 4 year follow up, 
cognitive decline greater in 
incident hypoglycaemia 
group than those without 
hypos (p=0.03). 
Bruce 2009 
[14] 
MMSE, IQCODE, 
question on subjective 
memory.  If MMSE <28 
or IQCODE >3.31, or 
subjective memory loss,  
detailed cognitive 
assessment and clinical 
review to diagnose 
dementia (DSM-IV) 
Self-reporting, 
investigator-assessed 
based signs, symptoms 
and availability of glucose 
measures, health service 
use for hypoglycaemia. 
Multiple logistic regression 
adjusted for: age, sex, 
education, CVD for cognitive 
impairment without dementia; 
PAD and duration of diabetes 
for dementia; 
CVD, PAD and duration of 
diabetes for all cognitive 
impairment. 
Dementia increases hypos:  
HR 3.02 (1.07, 8.52), but 
hypoglycaemia does not 
cause cognitive impairment 
(authors state no significant 
difference, but figures not 
given) 
De Galan 
2009 [17] 
MMSE at baseline entry 
to trial 
Symptoms without 
apparent cause or blood 
glucose <2.8mmol/L, 
adverse events reports in 
a trial. 
Cox models Severe cognitive 
dysfunction increased risk of 
severe hypos: HR 2.10 
(1.14, 3.87) 
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Feil 2011 
[9] 
ICD9-CM, NCQA 
dementia code schema 
ICD9-CM codes 
combined from OP visits, 
emergency department, 
and inpatient encounters 
with an admission 
diagnosis of 
hypoglycaemia 
Multiple regression analysis in 
total sample, stratified analysis 
in subsamples. Adjustments 
for diabetes drugs and disease 
burden, demographics, 
nursing home stay 
Dementia and cognitive 
impairment independently 
associated with greater risk 
of hypos: OR 1.57 (1.53, 
3.87) based on fully 
adjusted Model 3 
Gao 2015 
[15] 
Peterson’s diagnostic 
standard on MCI 
MMSE, Wechsler Adult 
Intelligence Scale 
(WAIS)-III Block Design, 
WAIS III Digit Span, Trail 
Making Test A & B, 
Weschler Memory Scale 
(WMS)-III Word List 
Learning, WMS-III 
Logical Memory, Verbal 
Fluency 
Self-reported Multiple logistic regression 
analysis used to examine 
association between diabetic 
factors and MMSE, Trails B, 
digit span, and block design 
Impaired performance in 
T2DM-MCI in MMSE, Trails 
B, digit span, and block 
design tests 
Self-reported history of 
severe hypoglycaemia was 
associated with T2DM-MCI 
independent of diabetes 
duration and vascular 
disease. 
OR not estimable 
Gorska 
2014 [19] 
MoCA, GDS-30, BADL, 
IADL 
Not stated – appears to 
rely on ‘history of 
hypoglycaemia’ 
Stepwise multivariable logistic 
regression including  gender, 
age, education, marital status, 
smoking, physical activity, 
diabetes duration, body mass 
index, HbA1c, lipids, treatment 
of T2DM, vascular 
complications, hypertension 
history and drugs, co-
morbidities 
Hypoglycaemia is a 
predictor for depressive 
symptoms/mild cognitive 
impairment: OR 2.27 ( 1.72, 
2.98) 
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Haroon 
2015 [12] 
New cases of dementia 
defined based on ≥1 
hospitalisation record or 
two outpatient billing 
claims (within six 
months) ICD-9 code. 
Algorithm validated 
against cognitive testing, 
with 73 and 94% positive 
and negative predictive 
values respectively.  
Healthcare administrative 
database records of 
hospitalisation or 
emergency department 
visits for hypoglycaemia  
Cox proportional hazard 
modelling with sensitivity 
analyses examining whether 
detection bias could explain 
elevated risk of dementia 
Adjusted for baseline income 
and co-morbidities, including 
hypertension, chronic kidney 
disease and vascular diseases 
of varying aetiologies. 
Hospitalisation and 
emergency department 
visits for hypoglycaemia 
were significant predictors of 
dementia aHR 1.73 (1.62, 
1.84) based on comparison 
of one or more episodes 
versus none. 
Lin 2012 
[18] 
ICD9-CM 
Method of diagnosing 
not stated 
ICD9-CM 
Method of diagnosing not 
stated 
Multivariable Cox proportional 
hazard analysis 
Age, gender, co-morbidities 
(Ischaemic heart disease, 
cardiovascular disease, 
hyperlipidaemia, chronic renal 
disease, hypertension), insulin 
use. 
Adult diabetic patients with 
prior hypoglycaemia had a 
significantly increased risk 
dementia: HR 1.45 (1.07, 
1.97).  Hypoglycaemia, age, 
female gender and insulin 
use independently predicted 
dementia 
Munshi 
2006 [16] 
MMSE, clock drawing 
test, Clock-in-a box test, 
GDS, questionnaires 
(ADLs, IADLs) 
Self-reporting Linear regression 
Multivariable analyses, 
controlling for age, sex, living 
status, BMI, duration of 
diabetes, depression, MMSE, 
education, co-morbidities 
Higher incidence of hypos in 
patients with cognitive 
dysfunction – but not 
statistically significant 
OR not estimable 
Punthakee 
2012 [8] 
Digit Symbol 
Substitution Test (subset 
of Wechsler Adult 
Intelligence Scale) 
Hypoglycaemia requiring 
medical assistance. 
Severe hypoglycaemia 
documented with plasma 
Multivariable Cox models 
adjusted for  age, education, 
language of test 
administration, depression 
Five point decrease in 
DSST associated with 
increased hypoglycaemia 
requiring medical 
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Rey Auditory Verbal 
Learning Test, Stroop 
Test, MMSE 
glucose  <2.8 or 
symptoms that promptly 
resolved with therapy 
assistance: OR 1.18 (1.04, 
1.33) 
Whitmer 
2009 [20] 
Inpatient and outpatient 
databases based on 
ICD9-CM 
Hospitalisation and ED 
diagnoses of 
hypoglycaemia using 
hospital/ED databases 
ICD9-CM 
Cox proportional hazard 
regression models, adjusted 
for age, sex, race/ethnicity, 
education, BMI, mean HbA1c, 
diabetes duration and 
treatment, 
History of severe 
hypoglycaemic episodes 
was associated with a 
greater risk of dementia: HR 
1.44 (1.25, 1.66) 
Yaffe 2013 
[11] 
Hospital records of 
admission associated 
with dementia or use of 
prescribed dementia 
medications 
Hospital records: severe 
hypos requiring 
admission and identified 
as primary or secondary 
diagnosis related to 
overnight hospitalisation.  
No information on milder 
hypos  
Cox Proportional Hazard 
Regression. Adjustments for 
age, educational level, 
race/ethnicity, and any other 
covariates significantly 
associated with severe 
hypoglycaemia or dementia in 
bivariate analysis 
Hypoglycaemia associated 
with increased risk of 
dementia: HR 2.09 (1.00, 
4.35) 
Subsequent Dementia is 
associated with 
hypoglycaemia events: HR 
3.10 (1.46, 6.58) 
 
OR= Odds ratio, HR=Hazard ratio, 95% CI= 95% Confidence Interval, T2DM=Type 2 diabetes mellitus, MMSE=mini mental state examination, ICD9-CM= 
International classification of diseases 9th revision clinical modification, GDS= Geriatric Depression Scale, ADL=Activities of daily living, IADL= Instrumental 
activities of daily living, BADL= Basic Activities of daily living, NCQA=National Committee for Quality Assurance, MoCA=Montreal Cognitive Assessment, 
MCI=mild cognitive impairment, DSM=Diagnostic and statistical manual of mental disorders
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